European AIDS Research Center to Test CombiMatrix siRNA against HIV | GenomeWeb

NEW YORK, June 30 - CombiMatrix is collaborating with the Retrovirology Laboratory irsiCaixa, an AIDS research center based in Barcelona, to test the efficacy of its pooled siRNA compounds against Human Immunodeficiency Virus, Type-1, the company said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.